A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

INTRODUCTION: To lower the barrier for initiating insulin treatment and obtain adequate glycemic control in type 2 diabetes mellitus (T2DM), new basal insulin preparations with improved pharmacological properties and consequently a lower risk of hypoglycemia are needed. The objective of this trial w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Changyu, Gross, Jorge L., Yang, Wenying, Lv, Xiaofeng, Sun, Li, Hansen, Charlotte Thim, Xu, Hongfei, Wagner, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875929/
https://www.ncbi.nlm.nih.gov/pubmed/27098525
http://dx.doi.org/10.1007/s40268-016-0134-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875929/
https://www.ncbi.nlm.nih.gov/pubmed/27098525
http://dx.doi.org/10.1007/s40268-016-0134-z

Ejemplares similares